INDEPENDENT NEWS

Fyfe-chaired medicinal cannabis firm gets $6 mln investment

Published: Fri 26 Apr 2019 06:48 PM
Fyfe-chaired medicinal cannabis firm gets $6 mln investment
By Rebecca Howard
April 26 (BusinessDesk) - Pure Cann New Zealand, which counts former Air New Zealand boss Rob Fyfe as its executive chair, has secured $6 million from Australia's Cann Group for a 20 percent stake in the local medicinal cannabis company.
The investment will be made over stages with the initial 10 percent to be completed on or before Aug. 30 and a further 10 percent when New Zealand regulations come into force and Pure Cann's board approves the construction of its commercial cultivation facility.
The New Zealand government anticipates introducing new regulations, licensing requirements and quality standards governing medicinal cannabis usage by the end of this calendar year.
ASX-listed Cann Group has the option to increase its position to 30 percent.
Fyfe, currently Pure Cann's second largest shareholder with a 25.2 percent stake, said the move is a "pivotal moment for New Zealand's medicinal cannabis industry."
The strategic investment and a technical services agreement - which allows for mutual sharing of intellectual property - "ensure that Pure Cann is now fully funded and, more importantly, allows us to leverage the cultivation, production and technical leadership of Cann Group," the former Icebreaker chair said.
The move lets the two companies work together to "capitalise on the growing demand for medicinal cannabis in New Zealand and explore potential export opportunities as Pure Cann develops its own proposed cultivation and production facilities," said Cann Group chief executive Peter Crock.
Cann Group has established research and cultivation facilities in Melbourne and is looking to provide access to medicinal cannabis for Australian patients. Aurora Cannabis, one of Canada's largest listed medicinal cannabis companies, owns 22.9 percent of the Australian firm.
"Pure Cann is proposing to develop a range of organic medicinal cannabis products to serve patient needs in New Zealand and potential export markets," Crock said. "We are confident that Pure Cann will be able to leverage New Zealand's global reputation for development world leading premium and natural products."
(BusinessDesk)
BusinessDesk
Independent, Trustworthy New Zealand Business News
The Wellington-based BusinessDesk team provides a daily news feed for a serious business audience.
Contact BusinessDesk
Email:

Next in Business, Science, and Tech

New era for Air New Zealand’s International Network
By: Air New Zealand
Government invests in Te Reo, environmental data research
By: New Zealand Government
27 percent increase in Trades Academy places
By: New Zealand Government
NZ company fined NZ$36,000 for unsolicited messages
By: Department Of Internal Affairs
EDS calls for urgent action on marine management
By: Environmental Defence Society
E tū: changing times as Air NZ cuts London services
By: E tu
Te Hiku Media awarded $13 million for language platform
By: Te Hiku Media
Bridges' officials claimed failed tech 'transformational'
By: RNZ
Using Data to Give Our Rivers a Voice
By: Seed The Change
Satellite-based remote lake health monitoring solution
By: Seequent
Government announces next steps in skills gap plan
By: New Zealand Government
Jacinda Ardern - Speech to CTU biennial conference
By: New Zealand Government
ITF welcomes additional vocational training places
By: Industry Training Federation
More Trades Academy places good news for primary sector
By: Primary ITO
Supported employers key to trades training review says MTA
By: Motor Trade Association
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media